These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 22535883

  • 1. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T.
    Song KD, Kim YK, Lee WJ, Lee MW, Park MJ, Hwang J, Lee MH.
    Acta Radiol; 2012 Jun 01; 53(5):485-93. PubMed ID: 22535883
    [Abstract] [Full Text] [Related]

  • 2. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun 01; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

  • 3. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 4. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul 01; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 5. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov 01; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 6. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods.
    Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J.
    Abdom Imaging; 2012 Feb 01; 37(1):74-82. PubMed ID: 21597893
    [Abstract] [Full Text] [Related]

  • 7. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT, Li WX, Chai WM, Chen KM.
    J Dig Dis; 2014 Mar 01; 15(3):137-45. PubMed ID: 24354621
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH, Choi D, Kim YS, Jang KM, Lee SJ, Lim HK.
    Invest Radiol; 2012 Mar 01; 47(3):159-66. PubMed ID: 22330426
    [Abstract] [Full Text] [Related]

  • 9. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA.
    Eur J Radiol; 2012 Aug 01; 81(8):e849-53. PubMed ID: 22575171
    [Abstract] [Full Text] [Related]

  • 10. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid.
    Ahn SJ, Kim MJ, Hong HS, Kim KA, Song HT.
    J Magn Reson Imaging; 2011 Aug 01; 34(2):310-7. PubMed ID: 21598345
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of breathhold, navigator-triggered, and free-breathing diffusion-weighted MRI for focal hepatic lesions.
    Choi JS, Kim MJ, Chung YE, Kim KA, Choi JY, Lim JS, Park MS, Kim KW.
    J Magn Reson Imaging; 2013 Jul 01; 38(1):109-18. PubMed ID: 23188562
    [Abstract] [Full Text] [Related]

  • 15. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease?
    Kwon S, Kim YK, Park HJ, Jeong WK, Lee WJ, Choi D.
    Magn Reson Imaging; 2014 Dec 01; 32(10):1214-22. PubMed ID: 25192607
    [Abstract] [Full Text] [Related]

  • 16. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
    Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B.
    Radiology; 2008 Mar 01; 246(3):812-22. PubMed ID: 18223123
    [Abstract] [Full Text] [Related]

  • 17. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    Radiology; 2012 Sep 01; 264(3):761-70. PubMed ID: 22843769
    [Abstract] [Full Text] [Related]

  • 18. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (<or=3 cm) detection].
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y, Chen CZ, Shen JZ, Li RC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):592-6. PubMed ID: 19595157
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
    Kim MY, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D.
    J Magn Reson Imaging; 2014 Jan 10; 39(1):31-41. PubMed ID: 24115329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.